The BCG Moreau Vaccine Upregulates In Vitro the Expression of TLR4, B7-1, Dectin-1 and EP2 on Human Monocytes

Overview

Journal Vaccines (Basel)

Date 2023 Jan 21

PMID 36679931

Authors

Paulo R Z Antas

Andreon S M da Silva

Lawrence H P Albuquerque

Matheus R Almeida

Evelyn N G S Pereira

Luiz R R Castello-Branco

Carlos G G de Ponte

Affiliations

Soon will be listed here.

Abstract

Background: Tuberculosis (TB) is currently the second greatest killer worldwide and is caused by a single infectious agent. Since Bacillus Calmette−Guérin (BCG) is the only vaccine currently in use against TB, studies addressing the protective role of BCG in the context of inducible surface biomarkers are urgently required for TB control. Methods: In this study, groups of HIV-negative adult healthy donors (HD; n = 22) and neonate samples (UCB; n = 48) were voluntarily enrolled. The BCG Moreau strain was used for the in vitro mononuclear cell infections. Subsequently, phenotyping tools were used for surface biomarker detection. Monocytes were assayed for TLR4, B7-1, Dectin-1, EP2, and TIM-3 expression levels. Results: At 48 h, the BCG Moreau induced the highest TLR4, B7-1, and Dectin-1 levels in the HD group only (p-value < 0.05). TIM-3 expression failed to be modulated after BCG infection. At 72 h, BCG Moreau equally induced the highest EP2 levels in the HD group (p-value < 0.005), and higher levels were also found in HD when compared with the UCB group (p-value < 0.05). Conclusions: This study uncovers critical roles for biomarkers after the instruction of host monocyte activation patterns. Understanding the regulation of human innate immune responses is critical for vaccine development and for treating infectious diseases.

Citing Articles

Vaccine Development against Infectious Diseases: State of the Art, New Insights, and Future Directions.

Conceicao Silva F, De Luca P, Lima-Junior J Vaccines (Basel). 2023; 11(11).

PMID: 38005964 PMC: 10674303. DOI: 10.3390/vaccines11111632.

References

Rousseau M, El-Zein M, Conus F, Legault L, Parent M . Bacillus Calmette-Guérin (BCG) Vaccination in Infancy and Risk of Childhood Diabetes. Paediatr Perinat Epidemiol. 2015; 30(2):141-8. DOI: 10.1111/ppe.12263. View

Nakayama M, Akiba H, Takeda K, Kojima Y, Hashiguchi M, Azuma M . Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood. 2009; 113(16):3821-30. DOI: 10.1182/blood-2008-10-185884. View

Zha Y, Blank C, Gajewski T . Negative regulation of T-cell function by PD-1. Crit Rev Immunol. 2004; 24(4):229-37. DOI: 10.1615/critrevimmunol.v24.i4.10. View

Bakhru P, Sirisaengtaksin N, Soudani E, Mukherjee S, Khan A, Jagannath C . BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9. Cell Immunol. 2014; 287(1):53-61. PMC: 4096037. DOI: 10.1016/j.cellimm.2013.11.007. View

Yu L, Wang L, Chen S . Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med. 2010; 14(11):2592-603. PMC: 4373479. DOI: 10.1111/j.1582-4934.2010.01127.x. View

Morris M, Surendran N . Neonatal Vaccination: Challenges and Intervention Strategies. Neonatology. 2016; 109(3):161-9. PMC: 4749499. DOI: 10.1159/000442460. View

Saikolappan S, Estrella J, Sasindran S, Khan A, Armitige L, Jagannath C . The fbpA/sapM double knock out strain of Mycobacterium tuberculosis is highly attenuated and immunogenic in macrophages. PLoS One. 2012; 7(5):e36198. PMC: 3344844. DOI: 10.1371/journal.pone.0036198. View

Kleinnijenhuis J, Oosting M, Joosten L, Netea M, van Crevel R . Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol. 2011; 2011:405310. PMC: 3095423. DOI: 10.1155/2011/405310. View

Khoury S, Sayegh M . The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity. 2004; 20(5):529-38. DOI: 10.1016/s1074-7613(04)00116-5. View

10.

Chen M, Divangahi M, Gan H, Shin D, Hong S, Lee D . Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med. 2008; 205(12):2791-801. PMC: 2585850. DOI: 10.1084/jem.20080767. View

11.

Benevolo-de-Andrade T, Monteiro-Maia R, Cosgrove C, Castello-Branco L . BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis--review. Mem Inst Oswaldo Cruz. 2005; 100(5):459-65. DOI: 10.1590/s0074-02762005000500002. View

12.

Antal-Szalmas P, Strijp J, Weersink A, Verhoef J, van Kessel K . Quantitation of surface CD14 on human monocytes and neutrophils. J Leukoc Biol. 1997; 61(6):721-8. DOI: 10.1002/jlb.61.6.721. View

13.

Levy O, Zarember K, Roy R, Cywes C, Godowski P, Wessels M . Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol. 2004; 173(7):4627-34. DOI: 10.4049/jimmunol.173.7.4627. View

14.

Behr M . Correlation between BCG genomics and protective efficacy. Scand J Infect Dis. 2001; 33(4):249-52. DOI: 10.1080/003655401300077180. View

15.

Leentjens J, Kox M, Stokman R, Gerretsen J, Diavatopoulos D, van Crevel R . BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study. J Infect Dis. 2015; 212(12):1930-8. DOI: 10.1093/infdis/jiv332. View

16.

El-Zein M, Parent M, Benedetti A, Rousseau M . Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies. Int J Epidemiol. 2009; 39(2):469-86. DOI: 10.1093/ije/dyp307. View

17.

Cambier C, OLeary S, OSullivan M, Keane J, Ramakrishnan L . Phenolic Glycolipid Facilitates Mycobacterial Escape from Microbicidal Tissue-Resident Macrophages. Immunity. 2017; 47(3):552-565.e4. PMC: 5610147. DOI: 10.1016/j.immuni.2017.08.003. View

18.

Ballinger M, Peters-Golden M, Moore B . Impaired neonatal macrophage phagocytosis is not explained by overproduction of prostaglandin E2. Respir Res. 2011; 12:155. PMC: 3287971. DOI: 10.1186/1465-9921-12-155. View

19.

Boniface K, Bak-Jensen K, Li Y, Blumenschein W, McGeachy M, McClanahan T . Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med. 2009; 206(3):535-48. PMC: 2699124. DOI: 10.1084/jem.20082293. View

20.

Hanekom W . The immune response to BCG vaccination of newborns. Ann N Y Acad Sci. 2006; 1062:69-78. DOI: 10.1196/annals.1358.010. View